Secondary analysis of the PORTICO IDE trial (675 high/extreme-risk aortic stenosis patients): at 30 days, severe prosthesis-patient mismatch in small annuli was 3.3% with Portico vs 3.0% Evolut and 26.3% SAPIEN 3; Portico had higher mean gradient than Evolut (8.5 vs 6.9 mmHg).
Secondary analysisn = 675
Fontana et al. Prosthesis-patient mismatch with intra-annular self-expanding valves: an analysis of the PORTICO IDE trial